XTL BIOPHARMACEUTICALS LTD. Comprehensive Income
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Comprehensive Income of -$1.03 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2025-04-30
| Period end | Comprehensive Income 12 month |
|---|---|
| 2024-12-31 | -$1.03M 20-F · filed 2025-04-30 |
| 2023-12-31 | -$1.78M 20-F · filed 2025-04-30 |
| 2022-12-31 | -$1.35M 20-F · filed 2025-04-30 |
| 2019-12-31 | -$1.35M 20-F · filed 2020-03-12 |
| 2018-12-31 | $2.99M 20-F · filed 2020-03-12 |
| 2017-12-31 | -$897.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | -$2.38M 20-F · filed 2019-03-11 |
| 2015-12-31 | -$4.31M 20-F · filed 2018-03-15 |